Linprixel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Linprixel, covering 2025-09-02 to 2025-09-02. Get the full timeline:
Most recent: Clinical Trial Update: A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia